EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Novel approaches to clinical trial design in cancer neuroscience

Gregory Jones, Jennifer L Anderson, Phuong T T Nguyen, Frederico O Gleber-Netto, William L Hwang, Vinay K Puduvalli, Michelle Monje, Moran Amit

Neuron · 2025-09 · 113 (17) · 2791-2813

DOI: 10.1016/j.neuron.2025.08.015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuron, 2025-09. Verfasst von Gregory Jones und 7 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Neoplasms, Clinical Trials as Topic, Antineoplastic Agents, Drug Repositioning. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 314 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emerging field of cancer neuroscience has revealed profound bidirectional interactions between the nervous system and cancer cells, identifying novel therapeutic vulnerabilities across diverse malignancies. This review examines the unique challenges and strategies for translating these insights into effective therapies. We propose innovative approaches to overcome these barriers through drug repurposing, enhanced biomarker development, and optimized trial designs. Repurposing neuroactive drugs with established safety profiles offers an accelerated path to clinical impact, particularly for targeting glutamatergic, adrenergic, and neurotrophic signaling pathways. Emphasizing mitigation of neurotoxicity and improved patient quality of life will be paramount moving forward. Repurposed agents that show preliminary potential for "dual use" (i.e., simultaneous toxicity mitigation and synergistic anti-tumor effects) are highlighted for special consideration. Master protocols and window-of-opportunity trials provide platforms to rapidly validate mechanisms while addressing patient-centered outcomes. By systematically addressing these foundational elements across disciplines, cancer neuroscience can translate its profound mechanistic insights into meaningful therapeutic advances for patients with treatment-resistant malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsClinical Trials as TopicAntineoplastic AgentsDrug RepositioningNeurosciencesResearch DesignHumansAnimals

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Center for Systems Biology, Krantz Family Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Center for Systems Biology, Krantz Family Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Me…
  • Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Cancer Neuroscience Program, The University of Texas MD Anderson Cancer Center, Houston, TX…
  • Department of Neurology and Neurological Sciences and Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA.

Förderung

  • NIDCR NIH HHS
  • NCI NIH HHS

Zitieren

APA

Jones, G., Anderson, J. L., Nguyen, P. T. T., Gleber-Netto, F. O., Hwang, W. L., Puduvalli, V. K., Monje, M., & Amit, M. (2025). Novel approaches to clinical trial design in cancer neuroscience. Neuron, 113(17), 2791-2813. https://doi.org/10.1016/j.neuron.2025.08.015

Vancouver

Jones G, Anderson JL, Nguyen PTT, Gleber-Netto FO, Hwang WL, Puduvalli VK, et al. Novel approaches to clinical trial design in cancer neuroscience. Neuron. 2025;113(17):2791-2813. doi:10.1016/j.neuron.2025.08.015

BibTeX
@article{Jones2025,
  author = {Jones, Gregory and Anderson, Jennifer L and Nguyen, Phuong T T and Gleber-Netto, Frederico O and Hwang, William L and Puduvalli, Vinay K and Monje, Michelle and Amit, Moran},
  title = {Novel approaches to clinical trial design in cancer neuroscience},
  journal = {Neuron},
  year = {2025},
  volume = {113},
  number = {17},
  pages = {2791--2813},
  doi = {10.1016/j.neuron.2025.08.015}
}
Kostenlos starten →